Reuters
Read the original →
UniQure to seek approval for Huntington's therapy after FDA U-turn, shares skyrocket
uniQure will seek approval for Huntington's disease gene therapy after switchup...
drugdiscoverynews.com · Jun 19, 2026 Standard
FDA opens path for uniQure’s Huntington’s gene therapy filing - European Biotechnology Magazine
european-biotechnology.com · Jun 18, 2026 Standard
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn - Pharmaceutical Technology
pharmaceutical-technology.com · Jun 18, 2026 Standard
UniQure Shares Soar After FDA Reversal on Its Huntington's Therapy
Bloomberg · Jun 17, 2026 Standard
UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again
biospace.com · Jun 17, 2026 Standard
UniQure stock surges after FDA U-turn clears path to gene therapy filing
fiercebiotech.com · Jun 17, 2026 Standard